Jean Pierre Frans Van Wauwe

The mitogenic activity of OKT3 and anti-Leu 4 monoclonal antibodies: a comparative study.

The mitogenic properties of OKT3 (IgG2a) and anti-Leu 4 (IgG1), two monoclonal antibodies directed at the same surface antigen of human T cells, have been studied. Both antibodies, at subnanomolar concentrations, induced thymidine incorporation of comparable magnitude into human peripheral blood mononuclear cell cultures. Their mitogenicity reached peak values 3 days after stimulation, was totally inhibitable by monoclonal OKT11A antibody, and was strictly dependent on the presence of monocytes as auxiliary cells. Whereas mononuclear cells from all blood donors tested were proliferative to OKT3, cells from 12 of 30 donors (40%) were unresponsive to anti-Leu 4. The incidence of this unresponsiveness was significantly higher for cells from female than male donors, showing 60 and 20% nonresponders, respectively. Anti-Leu 4 unresponsiveness was found to be due to the inability of autologous monocytes to exert their auxiliary function; thus, lymphocytes from anti-Leu 4 nonresponders became mitogenically inducible by anti-Leu 4 after addition of monocytes from anti-Leu 4 responders, whereas lymphocytes from anti-Leu 4 responders failed to respond to anti-Leu 4 after supplementation of monocytes from anti-Leu 4 nonresponders. Considering the different immunoglobulin subtype of OKT3 (IgG2a) and anti-Leu 4 (IgG1), our results indirectly suggest that the auxiliary function of monocytes is mediated by their Fc receptors. Unresponsiveness to anti-Leu 4 could then be explained by the absence, paucity, or functional deficiency of monocytic Fc receptors for IgG1.

Inhibition of lymphocyte proliferation by monoclonal antibody directed against the T3 antigen on human T cells

Peripheral blood mononuclear cells from 40% of normal donors are mitogenically unresponsive to UCHT1, a monoclonal antibody reactive to the T3 surface molecule on human T lymphocytes. Cell preparations from non-UCHT1 responders were used to examine whether and how interaction of UCHT1 with the T3 molecule affects T-cell functionality. It was found that UCHT1 profoundly (greater than 85%) suppressed lymphocyte proliferation induced by plant mitogens (phytohemagglutinin (PHA) and concanavalin A (Con A], recall antigen (candidin), and allogeneic non-T cells. The antibody abrogated both the production of interleukin 2 (IL-2) by and the expression of IL-2-specific receptors on T lymphocytes stimulated by PHA or allogeneic non-T cells. UCHT1 was maximally suppressive when added to cells within 2 hr (PHA stimulation) or 1 day (allogeneic non-T cell activation) after the initiation of the culture period. The inhibiting activity of UCHT1 could be related to its ability to modulate T3 molecules from the T-cell surface: both actions displayed the same antibody concentration dependence and had a comparable time dependence. Moreover, after modulation, unresponsive lymphocytes regained responsiveness to PHA in parallel with reexpression of surface T3 molecules. These findings are consistent with the idea that the human T3 molecule functions as an essential signal transducer during the early phases of T-cell activation.

Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: novel series of PDE4 inhibitors

This communication describes the synthesis and in vitro PDE4 inhibitory activity of a novel series of imidazol-2-one and 2-cyanoiminoimidazole derivatives. The compounds described were also tested in in vivo models to evaluate their anti-inflammatory activity after topical administration as well as their gastro-intestinal side effects. Several compounds proved to be potent PDE4 inhibitors and some 2-cyanoiminoimidazoles showed less pronounced gastro-intestinal side effects than reference compounds but maintained anti-inflammatory activity after topical administration.

5-sulfonyl-benzimidazoles as selective CB2 agonists-part 2.

In a previous communication, the SAR of a series of potent and selective 5-sulfonyl-benzimidazole CB2-receptor agonists was described. The lack of in vivo activity of compounds from this series was attributed to their poor solubility and metabolic stability. In this Letter, we report on the further optimization of this series, leading to the relatively polar and peripherically acting CB2 agonists 41 and 49. Although both compounds were not active in acute pain models, the less selective compound 41 displayed good, sustained activity in a chronic model of neuropathic pain without the tolerance observed with morphine. In addition, both 41 and 49 delayed the onset of clinical symptoms in an experimental model for Multiple sclerosis.

E-rosette formation at 37 °C: Analysis with monoclonal OKT antibodies

Abstract When cultured in the presence of PHA, a proportion of human peripheral blood mononuclear cells acquires the capacity to form E rosettes with sheep erythrocytes that are resistant to incubation at 37 °C. The nature of this 37 °C stable E-rosette formation was investigated using a panel of monoclonal OKT antibodies directed to human T-lymphocyte surface antigens. OKT11A antibody, at a concentration of 0.2–0.4 μg/ml, markedly blocked 37 °C E rosetting. OKT1, OKT3, OKT4, OKT6, and OKT8 antibodies, when tested at 10 μg/ml, show no such inhibiting activity. Quantitative studies with 125 I-labeled OKT11A indicated that the antibody interacted strongly with both 37 °C E-rosetting and nonrosetting cells, the association constant being 1.6–2.0 × 10 9 M −1 . However, on the average, a threefold higher concentration of OKT11A receptor sites was found on 37 °C E-rosette-forming cells (14.8 × 10 4 sites/cell) than on nonrosetting cells (4.8 × 10 4 sites/cell). Our data suggest that 37 °C E-rosette formation is governed by a lymphocyte surface determinant recognized by OKT11A antibody. “Overexpression” of OKT11A antigenic sites on a proportion of PHA-stimulated lymphocytes may explain their capacity to form 37 °C stable E-rosettes.

Lack of immunosuppression by ketoconazole and itraconazole

The antifungal drugs ketoconazole and itraconazole were evaluated for their effects in the following test systems: in vitro, phytohaemagglutinin (PHA)-induced proliferation of human peripheral blood mononuclear cells and IL-2-driven proliferation of CTLL-2 cells; in vivo, antibody response to sheep red blood cells (SRBC) and delayed-type hypersensitivity (DTH) reaction to oxazolone. At a concentration of 10 microM, ketoconazole moderately and itraconazole strongly inhibited thymidine (Thd) incorporation in human peripheral blood mononuclear cells cultured in medium supplemented with 5% human serum. Increasing the serum concentration from 5 to 20% almost completely reversed these inhibitory effects. Also, cell viability, found to be less than 15% in cultures containing 10 microM itraconazole was restored by increasing the serum concentrations in the culture medium. Similar observations were made in experiments using IL-2-stimulated CTLL-2 cells: the growth inhibition in the presence of 10 microM ketoconazole or 1 microM itraconazole could be counteracted by increased serum supplementation. In vivo, subchronic intraperitoneal dosing with 40 mg/kg ketoconazole or itraconazole to mice had no effect on the antibody response to SRBC as measured by the number of splenic IgM and IgG plaque-forming cells and did not significantly affect the DTH response to oxazolone. These data indicate that neither ketoconazole nor itraconazole exert immunosuppressive properties in vivo. Their in vitro inhibitory effects on PHA-induced lymphocyte proliferation and IL-2-dependent CTLL-2 growth are reversed by the serum supplementation to the culture medium and these activities should therefore be considered as in vitro artefacts.

CD3 modulation inhibits pokeweed mitogen-induced T-cell help for immunoglobulin production

The CD3 molecule is considered to be a signal transducer in the process of T-cell activation. Modulation of the CD3 molecule of peripheral blood T cells can be accomplished by incubation at 37 degrees C with UCHT-1, a mouse IgG1 anti-CD3 monoclonal antibody, under experimental conditions avoiding T-cell activation. We have examined the effect of CD3 modulation on T-cell-dependent polyclonal immunoglobulin (Ig) production induced by pokeweed mitogen (PWM) in cultures of peripheral blood lymphocytes. CD3 modulation strongly inhibited (greater than 80%) IgG and IgM production. This was due to inhibition of the production of soluble helper factors by the T cells, and not to induction of suppressor cells. These data support the concept that the CD3 molecule is an essential signal transducer in the process of PWM-induced helper T-cell activity, and that CD3 can function as a receptor transmitting negative signals to helper T cells.